← Back to Search

Neurostimulation Device

ReActiv8 Therapy for Chronic Lower Back Pain (RESTORE Trial)

N/A
Waitlist Available
Research Sponsored by Mainstay Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intractable Chronic Low Back Pain that has persisted >6 months resulting in pain most of the days in the past 12 months
Not a candidate for spine surgery
Must not have
BMI > 35
Any surgical correction procedure for scoliosis at any time, or a current clinical diagnosis of moderate to severe scoliosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare ReActiv8 Therapy to Optimal Medical Management (OMM) for treating people with Patellofemoral Pain Syndrome (PFPS).

Who is the study for?
This trial is for adults over 21 with chronic lower back pain that's severe enough to disrupt daily life but not suitable for spine surgery. Participants must have tried and failed other treatments like medications and physical therapy, have a specific disability score, and show muscle dysfunction in the lower back.
What is being tested?
The study compares ReActiv8 Therapy—a device designed to stimulate muscles supporting the lumbar spine—with Optimal Medical Management (OMM), which includes various non-surgical treatments. Patients are randomly assigned to one of these two approaches.
What are the potential side effects?
While specific side effects aren't listed here, generally such devices can cause discomfort at the implant site, potential nerve or tissue damage during insertion, infection risk, and possible device malfunction.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had chronic low back pain for more than 6 months.
Select...
I am not eligible for spine surgery.
Select...
My back pain level is between 6 and 9 on a scale of 0 to 10.
Select...
My back pain moderately affects my daily activities.
Select...
I am 21 years old or older.
Select...
I have issues with a back muscle called the lumbar multifidus.
Select...
I have had chronic low back pain for more than 6 months.
Select...
I am not eligible for spine surgery.
Select...
My back pain level is between 6 and 9 on a scale of 0 to 10.
Select...
My back pain moderately affects my daily activities.
Select...
I am willing and able to give my consent for treatment.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My BMI is over 35.
Select...
I have had surgery for scoliosis or currently have moderate to severe scoliosis.
Select...
My MRI shows a problem in my back that can be fixed with surgery.
Select...
My leg pain is worse than my back pain, or I have nerve pain below the knee.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Oswestry Disability Index (ODI)
Secondary study objectives
Change in EQ-5D
Change in Low Back Pain Numerical Rating Scale (LBP NRS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment (ReActiv8)Experimental Treatment1 Intervention
Market-approved ReActiv8 device
Group II: Control (OMM)Active Control1 Intervention
Standard of Care

Find a Location

Who is running the clinical trial?

Mainstay MedicalLead Sponsor
4 Previous Clinical Trials
407 Total Patients Enrolled
Chris GilliganStudy ChairBrigham and Women's Hospital
Kiran PatelStudy ChairNorthwell Health

Media Library

ReActiv8 (Neurostimulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT04803214 — N/A
Chronic Lower Back Pain Research Study Groups: Treatment (ReActiv8), Control (OMM)
Chronic Lower Back Pain Clinical Trial 2023: ReActiv8 Highlights & Side Effects. Trial Name: NCT04803214 — N/A
ReActiv8 (Neurostimulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04803214 — N/A
Chronic Lower Back Pain Patient Testimony for trial: Trial Name: NCT04803214 — N/A
~53 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top